HHS Announces Contract to Fund Development of Ebola Drug

BARDA will provide funding and access to subject-matter expertise and technical support toward the goal of FDA approval for ZMapp, an experimental medication.

The U.S. Department of Health and Human Services announced that its Office of the Assistant Secretary for Preparedness and Response has entered into a contract to support the development of a drug to treat Ebola patients. The $24.9 million, 18-month contract with Mapp Biopharmaceutical Inc., of San Diego, Calif., can be extended to a total of $42.3 million, according to the Sept. 2 news release.

ASPR's Biomedical Advanced Research and Development Authority will provide funding and access to subject-matter expertise and technical support for manufacturing, regulatory, and non-clinical activities. Work under the contract supports the development and manufacturing of an experimental medication named ZMapp toward the goal of U.S. Food and Drug Administration approval.

"While ZMapp has received a lot of attention, it is one of several treatments under development for Ebola, and we still have very limited data on its safety and efficacy," said Dr. Nicole Lurie, assistant secretary for preparedness and response. "Developing drugs and vaccines to protect against Ebola as a biological threat has been a long-term goal of the U.S. government, and today's agreement represents an important step forward."

Mapp Biopharmaceutical will manufacture a small amount of the drug for early-stage clinical safety studies and nonclinical studies needed to demonstrate ZMapp's safety and efficacy in people, and the company will work with BARDA on the manufacturing process, increasing production yields, and the scale of manufacturing.

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • The Top 5 Safety and Technology Trends to Watch

    Get the latest on trends you can expect to hear more about in 2019, including continued growth of mobile safety applications, wearable technology, and smart PPE; autonomous vehicles; pending OSHA recordkeeping rulemaking; and increased adoption of international safety standard, ISO 45001.

  • Analyze Incident Data

    Collect relevant incident data, analyze trends, and generate accurate regulatory reports, including OSHA 300, 300A, and 301 logs, through IndustrySafe’s extensive incident reporting and investigation module.

  • Safety Training 101

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common training questions.

  • Conduct EHS Inspections and Audits

    Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Industry Safe
comments powered by Disqus

OH&S Digital Edition

  • OHS Magazine Digital Edition - January 2019

    January / February 2019

    Featuring:

    • PREVENTING ERRORS
      Production vs. Safety 
    • EMERGENCY SHOWERS & EYEWASH
      Meeting the Requirements for Emergency Equipment
    • CONSTRUCTION SAFETY
      The State of Contractor Safety
    • FOOT PROTECTION
      The Three Keys to Effective Chemical Management
    View This Issue